公开(公告)号：US11564962B2

公开(公告)日：2023-01-31

申请号：US16325958

申请日：2017-08-11

Applicant: KOREA INSTITUTE OF ORIENTAL MEDICINE

Inventor： Jin Yeul Ma ,  Kwang Il Park ,  Yeoun-Hee Kim ,  Tae Woo Oh ,  Won Kyung Cho ,  Dong-Gun Kim ,  Eun Hee Park

IPC: A61K36/20 ,  A23L33/105 ,  A61P27/02

Abstract: The present invention relates to a pharmaceutical composition comprising a maple leaf extract or fraction thereof for preventing or treating a retinal disease, a method for preventing or treating a retinal disease using the pharmaceutical composition, and a food composition comprising a maple leaf extract or fraction thereof for ameliorating the symptoms of a retinal disease.
The pharmaceutical composition according to the present invention, which is effective for the treatment of a retinal disease, can be used pharmaceutically as a composition for preventing or treating a retinal disease, and can also be used advantageously as a health functional food.

公开(公告)号：US10357528B2

公开(公告)日：2019-07-23

申请号：US15742391

申请日：2016-07-08

Applicant: KOREA INSTITUTE OF ORIENTAL MEDICINE

Inventor： Jin Yeul Ma ,  Jung Hyun Kim ,  Jong Wook Jeon ,  You Chang Oh ,  Won Kyung Cho ,  Youn Hwan Hwang ,  Nam Hui Yim ,  Jae Myung Yoo

IPC: A61P27/02 ,  A61K36/20 ,  A61K9/08 ,  A61K36/77 ,  A61K9/00 ,  A61K47/02

Abstract: The present invention relates to a pharmaceutical composition for preventing and treating corneal diseases or conjunctival diseases, containing a maple leaf extract as an active ingredient. The maple leaf extract exhibits an effect of inhibiting hyperemia in the eyeball in which hyperemia has been induced and an effect of inhibiting angiogenesis in the eyeball in which corneal damage has been induced, thus being effectively used in a pharmaceutical composition for preventing and treating corneal diseases or conjunctival diseases.